首页> 外文期刊>Clinical ophthalmology >Intravitreal bevacizumab injection and carotid artery stent replacement for neovascular glaucoma in internal carotid artery occlusion
【24h】

Intravitreal bevacizumab injection and carotid artery stent replacement for neovascular glaucoma in internal carotid artery occlusion

机译:玻璃体内贝伐单抗注射和颈动脉支架置换术治疗颈内动脉阻塞的新生血管性青光眼

获取原文
           

摘要

Abstract: Neovascular glaucoma (NVG) secondary to internal carotid artery (ICA) occlusion is usually resistant to treatment. We report a case of NVG with ICA occlusion improved by intravitreal bevacizumab (IVB) injection and carotid artery stent replacement (CAS), even though we did not perform panretinal photocoagulation. A 67-year-old male with NVG noted visual loss in his left eye. Magnetic resonance angiography showed left ICA occlusion. He was diagnosed with NVG secondary to ICA occlusion. The next day, we carried out IVB injection in his left eye, following which the iris and angle neovascularization regressed, and the intraocular pressure decreased to normal within a day after the injection. CAS was performed on his left ICA at a month post injection. Two months later, we reinjected bevacizumab in his left eye. His condition remained stable with no recurrence over two years. This case indicates that IVB injection and CAS are useful for early-stage NVG secondary to ICA occlusion.
机译:摘要:继发于颈内动脉(ICA)闭塞的新生血管性青光眼(NVG)通常对治疗有抵抗力。我们报告了一例通过玻璃体内贝伐单抗(IVB)注射和颈动脉支架置换术(CAS)改善了ICA闭塞的NVG病例,即使我们未进行全视网膜光凝治疗。一名患有NVG的67岁男性注意到左眼视力下降。磁共振血管造影显示左ICA闭塞。他被诊断出继发于ICA闭塞的NVG。第二天,我们在他的左眼进行了IVB注射,随后虹膜和角膜新生血管逐渐消退,并且眼压在注射后的一天之内下降至正常水平。注射后一个月对左ICA进行CAS。两个月后,我们在他的左眼中重新注射了贝伐单抗。他的病情稳定,两年没有复发。这种情况表明,IVB注射和CAS对继发于ICA闭塞的早期NVG有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号